Esophageal cancer remains one of the world's deadliest cancers, ranking 7th in incidence and 6th in cancer-related deaths ...

This form of vitamin B3 is linked to reduced incidence of non-melanoma skin cancer in high-risk populations. (Getty Images) ...

The frequency of TI-CH and its effect on tumor evolution are unclear. We characterized CHIP and TI-CH in 421 patients with early-stage non–small ... promotion of tumor organoid growth.

However, metformin did not protect Black patients against squamous cell carcinoma specifically. “This study strengthens the evidence supporting metformin's potential as a protective agent ...

The study results confirmed that the organoid’s response to therapy mirrored the response of the actual tumor in the patient’s brain, so if the tumor-derived organoid shrank after treatment ...

Yet the most common types of skin cancer are basal and squamous cells, and they rarely spread through your body. Your treatment for non-melanoma cancers may include radiation or chemotherapy ...

Krönert MIC, Schwarzenböck SM, Kurth J, et al. Patient-orientated evaluation of treatment of non-melanoma skin cancer with rhenium-188 compared to surgery. Healthcare (Basel) . 2024;12(9):921 ...

Maryna Panamarova (left) is a Cellular Modelling Technical Specialist at the Wellcome Sanger Institute (Cambridge, UK), in the scientific operations department. The scientific operations department ...

Because the new organoid is more complex than previous models, scientists can study not only which cells give rise to colorectal cancer but also how the individual cells within those tumors differ ...

“If a drug had no effect on the tumor organoid, then this treatment would also have no effect on the patient – and vice versa,” said Oliver Sieber, the study’s corresponding autho ...

Visit LetsGetRealAboutSkinCancer.com to learn more about non-melanoma skin cancer, including some of its features in people of color, and to take a pledge to see a dermatologist for a skin check.

To this end, a research team from Japan attempted to create cancer cell organoid systems that can effectively resemble PDAC and act as a screening tool in anticancer research. Dr. Takeuchi Kenta ...